Gilead to buy cancer drugmaker Immunomedics in $21 billion deal

Aqeel September 13, 2020 0

The deal will provide Gilead access to Immunomedics' cancer treatment drug called Trodelvy, an FDA-approved treatment for metastatic triple-negative breast cancer.

from International: Top News And Analysis https://ift.tt/33iR9A0

No comments

Subscribe to: Post Comments ( Atom )